Transcription, Chromatin, and Epigenetics
Histone Arg Modifications and p53 Regulate the Expression of OKL38, a Mediator of Apoptosis*

https://doi.org/10.1074/jbc.M802940200Get rights and content
Under a Creative Commons license
open access

Protein Arg methyltransferases function as coactivators of the tumor suppressor p53 to regulate gene expression. Peptidylarginine deiminase 4 (PAD4/PADI4) counteracts the functions of protein Arg methyltransferases in gene regulation by deimination and demethylimination. Here we show that the expression of a tumor suppressor gene, OKL38, is activated by the inhibition of PAD4 or the activation of p53 following DNA damage. Chromatin immunoprecipitation assays showed a dynamic change of p53 and PAD4 occupancy and histone Arg modifications at the OKL38 promoter during DNA damage, suggesting a direct role of PAD4 and p53 in the expression of OKL38. Furthermore, we found that OKL38 induces apoptosis through localization to mitochondria and induction of cytochrome c release. Together, our studies identify OKL38 as a novel p53 target gene that is regulated by PAD4 and plays a role in apoptosis.

Cited by (0)

*

This work was supported, in whole or in part, by National Institutes of Health Grant GM079357 (to P. R. T.). This work was also supported by a startup fund from Pennsylvania State University (to Y. W.) and a TSF seed grant award from Johnson & Johnson Inc. and Pennsylvania State University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains supplemental Experimental Procedures, additional references, and Figs. S1–S7.